Literature DB >> 24931323

More about surfactant, oxygen, caffeine and chronic lung disease.

Máximo Vento, Tore Curstedt, Henry L Halliday, Mikko Hallman, Ola D Saugstad, Christian P Speer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24931323     DOI： 10.1159/000360653

Source DB:  PubMed          Journal:  Neonatology        ISSN： 1661-7800            Impact factor:   4.035


× No keyword cloud information.
  2 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.

Authors:  Walusa Assad Gonçalves Ferri; Adriana Carnevale da Silva; Eliana Motta Fernandes Sacramento; Cristina Calixto; Davi Casale Aragon; Jamil Pedro de Siqueira Caldas
Journal:  Rev Paul Pediatr       Date:  2020-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.